Taken together, our study reveals the specific cellular mechanisms via which ErbB4 regulates energy balance, highlighting ErbB4 in the PVN as a novel therapeutic target for obesity. Here, ERBB4 is linked to obesity due to melanocortin 4 receptor deficiency.